Chengdu Huasun Technology Group Inc Ltd
000790
Company Profile
Business description
Chengdu Huasun Technology Group Inc Ltd is engaged in the production and distribution of traditional Chinese medicines and chemical drugs in China. The company does its business in industries such as Modern Chinese Medicine, Bio-pharmacy, Health Industry, and Building Steel Structure. The company's product consists of Sanqi tongsu capsule, Biyuanshu oral liquid, Huolishu oral liquid, and Smokeless moxa stick.
Contact
1168 Fuxin Avenue, High-tech Zone (West District)
No. 101, 1st Floor, Building 2
Sichuan
Chengdu611731
CHNT: +86 2866616680
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
918
Stocks News & Analysis
stocks
PayPal earnings: Growth slows, new CEO appointed
We expect to lower our fair value estimate of PayPal stock.
stocks
Morningstar initiates on ASX income play
This REIT may be an option for investors seeking income.
stocks
What Goodman’s upcoming earnings could reveal about data centre & AI growth
Answering key questions about Goodman & its data centre pipeline ahead of earnings
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,149.30 | 6.90 | -0.08% |
| CAC 40 | 8,179.50 | 1.67 | -0.02% |
| DAX 40 | 24,780.79 | 16.73 | -0.07% |
| Dow JONES (US) | 49,180.53 | 227.13 | -0.46% |
| FTSE 100 | 10,314.59 | 26.97 | -0.26% |
| HKSE | 26,834.77 | 59.20 | 0.22% |
| NASDAQ | 23,192.65 | 399.46 | -1.69% |
| Nikkei 225 | 54,720.66 | 2,065.48 | 3.92% |
| NZX 50 Index | 13,421.52 | 9.08 | 0.07% |
| S&P 500 | 6,908.37 | 68.07 | -0.98% |
| S&P/ASX 200 | 8,857.10 | 9.20 | -0.10% |
| SSE Composite Index | 4,067.74 | 51.99 | 1.29% |